SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Gossamer Bio to present at Cantor Global Healthcare conference

Gossamer Bio, Inc. said it will present at the Cantor Global Healthcare Conference. The company is focused on seralutinib for pulmonary arterial hypertension (PAH) and PH-ILD.

GOSS

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories